• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HUANG Pei,YU Yanan,HUANG Xiaobin,LI Xiaozhi,CHEN Xixin,LIU Yi,CHEN Lei,WANG Shumei.Virtual screening for GLUT4 transporter agonists in flavonoids of Sophora flavescens[J].Journal Of Pharmaceutical Research,2018,37(5):249-252,290[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3700times   Download 3504次 QR Code for this article
Scan with your phone!
苦参黄酮类化合物中GLUT4转运蛋白激动剂的虚拟筛选
黄佩南1,于雅楠1,黄晓斌1,李晓芝1,陈锡欣1,刘怡2,陈磊1,3,4,王淑美1,3,4
Font:Larger+|Default|Smaller-
(1.广东药科大学中药学院,广东 广州 510006;2.南方医科大学中医药学院,广东 广州 510515;1.广东药科大学中药学院,广东 广州 510006;3.国家中医药管理局中药数字化质量评价技术重点实验室,广东 广州 510006;4.广东省中药质量工程技术研究中心,广东 广州 510006)
摘要:
目的 采用分子对接技术虚拟筛选苦参黄酮类化合物中葡萄糖转运蛋白4(GLUT4)转运蛋白激动剂。方法 搜集现已分离鉴定的128个苦参黄酮类化合物组成配体数据库,检索RCSB PDB数据库中葡萄糖转运蛋白4蛋白晶体结构并确定本研究用优势构象,以蛋白优势结构对应DrugBank中已上市的小分子药物平均打分为阈值,应用Discovery Studio 2.5(DS2.5)软件的CDOCKER模块进行分子对接。结果 虚拟筛选出打分高于阈值且排名前10%的化合物共12个并归纳了苦参黄酮作用靶点的主要活性位点,初步揭示了苦参黄酮抗糖尿病的作用机制。结论 基于分子对接的虚拟筛选可推断苦参黄酮化合物中促进GLUT4转运蛋白激动的有效成分,为进一步构效关系研究及研发基于新靶点的抗糖尿病类药物提供了一定的参考。
关键词:  苦参黄酮  糖尿病  分子对接  葡萄糖转运蛋白4
DOI:10.13506/j.cnki.jpr.2018.05.001
基金项目:国家级大学生创新创业训练计划项目(No.201610573010);国家自然科学基金项目(No.81403063、81673556);广东省基础与应用基础研究专项资金(省自然科学基金资助)项目(No.2017A030313753)
Virtual screening for GLUT4 transporter agonists in flavonoids of Sophora flavescens
HUANG Pei1,YU Yanan1,HUANG Xiaobin1,LI Xiaozhi1,CHEN Xixin1,LIU Yi2,CHEN Lei1,3,4,WANG Shumei1,3,4
(1.School of Traditional Chinese Medicine,Guangdong Pharmaceutical University,Guangzhou 510006,China;2.School of Chinese Medicine,Southern Medical University,Guangzhou 510515,China;3.Key Laboratory of Traditional Chinese Medicine Digitalization Quality Evaluation under State Administration of Traditional Chinese Medicine,Guangzhou 510006,China;4.Research Center for Traditional Chinese Medicine Quality Engineering Technology under Guangdong University,Guangzhou 510006,China)
Abstract:
Objective To investigate GLUT4 agonist in flavonoids of Sophora flavescens by virtual screening.Methods The database of 128 flavonoids from Sophora flavescens compound ligands was collected and the crystal structure of GLUT4 protein in the RCSB PDB database was searched and determined.In addition,the small-molecule approved drugs of targets from DrugBank database were set as a reference with minimum score as threshold,and the CDOCKER module of Discovery Studio 2.5 (DS2.5) software was used for molecular docking.Results The scores of top 10% of total 12 compounds were screened out and the mechanism of flavonoids anti-diabetes was preliminarily revealed.Conclusion Virtual screening based on molecular docking can be used to infer the active ingredients of the flavonoids of Sophora flavescens that promote the activation of GLUT4 transporters, and providing a certain reference for further structure-activity relationship studies and the development of antidiabetic drugs based on new targets.
Key words:  Flavonoids from Sophora flavescens  Diabetes mellitus  Molecular Docking  GLUT4
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.